Teva

Teva strides ahead in Q2

Teva strides ahead in Q2

By Anna Lewcock

Generics giant Teva has announced results for the second quarter of
the financial year showing record-breaking sales, thanks to an
impressive performance from MS drug Copaxone (glatiramer acetate)
and the early launch of generic Lotrel...